Last Price
0.427
Today's Change
+0.148 (53.04%)
Day's Change
0.385 - 0.588
Trading Volume
213,047,285
Market Cap
2 Million
Shares Outstanding
6 Million
Avg Volume
1,690,335
Avg Price (50 Days)
0.41
Avg Price (200 Days)
1.99
PE Ratio
0.00
EPS
-128.02
Earnings Announcement
14-Mar-2025
Previous Close
0.28
Open
0.53
Day's Range
0.385 - 0.5878
Year Range
0.233 - 38.1
Trading Volume
213,611,413
1 Day Change
50.31%
5 Day Change
62.25%
1 Month Change
-11.31%
3 Month Change
-15.77%
6 Month Change
-36.67%
Ytd Change
-5.89%
1 Year Change
-98.55%
3 Year Change
-99.72%
5 Year Change
-99.72%
10 Year Change
-99.72%
Max Change
-99.72%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.